|
1. |
Use of a Fully Implantable Drug Delivery System in the Treatment of Acute Leukemias and Disseminated Lymphomas |
|
Oncology,
Volume 47,
Issue 6,
1990,
Page 449-455
L. Schmid,
K. Walser,
W. Kessler,
H.J. Senn,
Preview
|
PDF (2908KB)
|
|
摘要:
In an open study, 42 venous Port-A-Cath® systems (PAC) were implanted in 40 patients with AML (12), ALL/AUL (11), NHL with bone marrow infiltration (8), Hodgkin’s lymphoma (3), solid tumors (5) and severe aplastic anemia (1). Mean duration of system use was 212 days. The cumulated duration of use of all systems was 8,883 days. 1,627 blood samples were taken from the PAC. Blood sampling was possible on 8,696 of 8,883 days of cumulated access (98%). A total of 522 blood transfusions were administrated. Fifty-two episodes of neutropenia (granulocyte counts < 0.5 × 109/l) with a mean duration of 17 days were observed in the group of the 23 patients with acute leukemias. A total of 25 complications were registered. The incidence was 2.8/1,000 days of access. Twelve complications were regarded as severe. Venous thrombosis was observed in 3 cases. In addition, there were 2 disruptions of the catheter, 1 disconnection, 1 looping and 4 local infections. The rate of systemic infection could not be accurately estimated because the catheter was always left in place and antibiotic treatment was started immediately in case of fever with or without bacteriemia. The overall rate of catheter-related complications in patients with acute leukemia was not higher than in patients with solid tum
ISSN:0030-2414
DOI:10.1159/000226870
出版商:S. Karger AG
年代:1990
数据来源: Karger
|
2. |
Serum Levels of Tumor-Associated Glycoprotein (TAG-72) in Digestive Cancers |
|
Oncology,
Volume 47,
Issue 6,
1990,
Page 456-462
Yoshiharu Motoo,
Yoshitake Satomura,
Hiroyasu Kawakami,
Hiroyuki Watanabe,
Hideki Ohta,
Takashi Okai,
Norio Sawabu,
Preview
|
PDF (2052KB)
|
|
摘要:
Serum levels of tumor-associated glycoprotein (TAG-72) were measured using a two-step sandwich radioimmunoassay kit in 281 patients with digestive cancers and 135 patients with benign digestive diseases. The positive rates of TAG-72 with the cut-off values of 2.2 and 4.0 U/ml were high in pancreatobiliary (56%, 38%), gastric (49%, 37%) and colorectal (62%, 29%) cancers, while the false-positive rate in benign diseases was 11%, 0.7% respectively. Very high levels were found in patients with advanced cancer. TAG-72 was positive in 17 (>2.2 U/ml) and 7 (>4.0 U/ml) out of 60 CEA-negative patients, and in 7 (>2.2 U/ml) and 3 (>4.0 U/ml) out of 17 CA19-9-negative patients. TAG-72 might be a useful serum marker for digestive cancers, especially gastric and colorectal cancers.
ISSN:0030-2414
DOI:10.1159/000226871
出版商:S. Karger AG
年代:1990
数据来源: Karger
|
3. |
Medical History, Diet and Pancreatic Cancer |
|
Oncology,
Volume 47,
Issue 6,
1990,
Page 463-466
Carlo La Vecchia,
Eva Negri,
Barbara D’Avanzo,
Monica Ferraroni,
Annagiulia Gramenzi,
Renzo Savoldelli,
Peter Boyle,
Silvia Franceschi,
Preview
|
PDF (1508KB)
|
|
摘要:
The relation between various aspects of medical history, selected indicator foods and the risk of pancreatic cancer was analyzed in a hospital-based case-control study conducted in Northern Italy on 247 patients with cancer of the pancreas, and 1,089 controls in hospitals for acute, nonneoplastic or digestive conditions. There was a significant association with history of pancreatitis (relative risk, RR 3.2, 95% confidence interval = 1.3–7.9), which was however reduced when the condition was first diagnosed at least 5 years previously. The point estimates were slightly, but not significantly, above unity for diabetes (RR = 1.5), gastrectomy (RR = 1.1) and cholelithiasis (RR = 1.3), and no association was found with liver disease or drug allergy. In relation to diet, there was some tendency for the risk to decrease with more frequent fruit consumption, but the results were largely inconsistent in relation to various indicators of meat, animal protein or fat intake. Although no important associations were found in this study with various aspects of medical history or diet indicators and pancreatic cancer risk, on account of the size of the dataset and the statistical power, this study contributes usefully to the debate on a common cancer whose causes are still largely undefine
ISSN:0030-2414
DOI:10.1159/000226872
出版商:S. Karger AG
年代:1990
数据来源: Karger
|
4. |
Variation of Estrogen and Progesterone Receptor Status in Breast Cancer after Tamoxifen Therapy |
|
Oncology,
Volume 47,
Issue 6,
1990,
Page 467-470
J.C. Melchor,
F.J. Rodríguez-Escudero,
S. Luján,
B. Corcóstegui,
Preview
|
PDF (1683KB)
|
|
摘要:
In the present paper we have studied the quantitative variations in estrogen (ER) and progesterone receptor (PR) content of breast cancer induced by tamoxifen. In addition to receptors, hormonal levels of estradiol, progesterone, prolactin, FSH, LH and testosterone were also measured. The cases included in our study were consecutively selected among those breast cancers in which an aliquot of the tissue sample sent for analysis of the steroid receptors was positive for cancer and also found to have at least one of the steroid receptors positive, not only in the biopsy but also in the surgical specimen. Following this criterion, we finally collected 14 cases of breast cancer treated daily with 30 mg of tamoxifen during an interval of 3 weeks from the initial biopsy to the final surgery. From our results we can conclude that tamoxifen reduced significantly the ER concentration while no changes were observed in PR values. Concerning hormones, while in premenopausal patients tamoxifen induced a rise in plasma estradiol, in postmenopausal women the only modification observed was a decrease in plasma FSH. The variation in steroid receptor content under tamoxifen therapy may also contribute to the evaluation of the hormone dependency of gynecologic malignancies.
ISSN:0030-2414
DOI:10.1159/000226873
出版商:S. Karger AG
年代:1990
数据来源: Karger
|
5. |
Multiple Malignant Neoplasms in Patients with Nasopharyngeal Carcinoma |
|
Oncology,
Volume 47,
Issue 6,
1990,
Page 471-474
Jonathan S.T. Sham,
William I. Wei,
Patricia T.H. Tai,
D. Choy,
Preview
|
PDF (1762KB)
|
|
摘要:
The records of 759 patients with nasopharyngeal carcinoma were reviewed. Fifteen of them also suffered from another malignant neoplasm. All patients had histological confirmation of the nasopharyngeal carcinoma and the other malignant neoplasm. There was no predilection for the second malignant neoplasms to arise from the bronchus. Although the observed number of second malignant neoplasms was not significantly different from the expected number (p >0.05) computed by the patient-month approach, in 1 patient the second malignant neoplasm may be causally related to the previous treatment of nasopharyngeal carcinoma by radiotherapy.
ISSN:0030-2414
DOI:10.1159/000226874
出版商:S. Karger AG
年代:1990
数据来源: Karger
|
6. |
Induction of Tumor Necrosis Factor in Human Peripheral-Blood Mononuclear Cells by Proteolytic Enzymes |
|
Oncology,
Volume 47,
Issue 6,
1990,
Page 475-477
Lucia Desser,
Alexander Rehberger,
Preview
|
PDF (1355KB)
|
|
摘要:
We could demonstrate that polyenzyme preparations as well as bromelain and papain stimulate the production of tumor necrosis factor-α in human peripheral-blood mononuclear cell cultures in a time-dependent manner. We give evidence that immunomodulation and especially the release of cytokines may contribute to the therapeutic effect of these preparations
ISSN:0030-2414
DOI:10.1159/000226875
出版商:S. Karger AG
年代:1990
数据来源: Karger
|
7. |
Flow-Cytometric Analysis of Colorectal Cancer with Hepatic Metastases and Its Relationship to Metastatic Characteristics and Prognosis |
|
Oncology,
Volume 47,
Issue 6,
1990,
Page 478-482
Akio Yamaguchi,
Tetsuya Ishida,
Shigeru Takegawa,
Genichi Nishimura,
Masahiro Kanno,
Takeo Kosaka,
Yutaka Yonemura,
Ryohei Izumi,
Itsuo Miyazaki,
Preview
|
PDF (2005KB)
|
|
摘要:
Studying the DNA ploidy patterns of 52 primary tumors, diploid tumors accounted for 48.1% and aneuploid tumors for 51.9%. Out of 31 patients with liver metastases, 35.5% had diploid tumors and 64.5%, aneuploid tumors. Heterogeneity (difference in DNA ploidy pattern between the primary lesion and liver metastases) was found in 20% of the patients examined. In 28 of the patients, the liver metastases were unresectable, and their prognoses were such that the 1- and 2-year survival rates from the diploid tumors were 42.9 and 14.3%, respectively, while 1-year survivors from aneuploid tumors died within 2 years. In resected cases of hepatic metastases, the DNA ploidy pattern of the metastatic lesions did not correlate with the metastasis period, extent of spread or number of lesions. The recurrence rate of aneuploid tumors in the residual livers was 50%, which was slightly higher than the rate of 36.4% for diploid tumors. The prognoses in patients with diploid tumors were significantly better than those in patients with aneuploid tumors: 5-year survival was 71.1% in diploid tumor patients, compared with 21% in aneuploid tumor patients.
ISSN:0030-2414
DOI:10.1159/000226876
出版商:S. Karger AG
年代:1990
数据来源: Karger
|
8. |
Differential Susceptibility of Metastatic Lymphoma Cells to Natural Immunity |
|
Oncology,
Volume 47,
Issue 6,
1990,
Page 483-487
Weimin Hao,
Shantaram S. Joshi,
Preview
|
PDF (2087KB)
|
|
摘要:
The susceptibility of metastatic variant lymphoma cells to natural immunity was studied using a low malignant/metastatic parental RAW 117-P cell line and its liver colonizing highly malignant/metastatic RAW117-H10 cell line. The metastatic variant RAW117-H10 cells express a significantly lower amount of laminin-like and fibronectin-like molecules as determined by flow cytometry using monospecific polyclonal antibodies to laminin and fibronectin. Our studies indicated that the RAW117-H10 cells are resistant to natural killer (NK) cell-mediated cytotoxicity. In vitro activation of the effector cells with interferon-gamma increased the susceptibility of these cells to NK-mediated cytotoxicity while maintaining the difference between the two cell lines. However, when recombinant interleukin-2 was used to activate the effector cells, the cytotoxicity of the lymphokine-activated effector cells to both parental low metastatic RAW117-P cells and highly metastatic RAW117-H10 cells was similar.
ISSN:0030-2414
DOI:10.1159/000226877
出版商:S. Karger AG
年代:1990
数据来源: Karger
|
9. |
Generation and Characterization of a Low-Degree Drug-Resistant Human Tumor Cell Line |
|
Oncology,
Volume 47,
Issue 6,
1990,
Page 488-494
Alessandra Mazzoni,
Fabio Trave,
Patrizia Russo,
Angelo Nicolin,
Youcef M. Rustum,
Preview
|
PDF (1567KB)
|
|
摘要:
A2780 human ovarian cancer cells, obtained from an untreated patient, have been exposed to a relatively low, clinically maintainable dose (10 nmol/l) of the anthracycline doxorubicin (DX) to derive a low-degree (5-fold) drug-resistant subline (A2780-DX1). Compared to parental cells, these DX-resistant cells have increased size (+60% of cell volume) and contain a greater number of cytoplasmic vacuoles as determined by electron microscopy. When exposed to several other antiproliferative drugs, A2780-DX1 cells were highly cross-resistant (>10-fold) to epirubicin, mafosfamide and cisplatin and slightly cross-resistant (2- to 3-fold) to navelbine and bleomycin, while they retained the original sensitivity to vinblastine, Ara-C and fluorouracil. Gel electrophoresis of cytoplasmic membrane proteins showed differences between the pattern of parental A2780 sensitive and A2780-DX1 cells as far as low-molecular-weight proteins (<45 kD) are concerned, while no clear overexpression of P-glycoprotein (P-170) could be detected. Membrane modifications yielding a decrease of both DX uptake and retention, increased content of intracellular glutathione (+32%) and reduced DNA double-strand breaks seem to be involved in the resulting multidrug-resistant phenotype of A2780-DX1 cells.
ISSN:0030-2414
DOI:10.1159/000226878
出版商:S. Karger AG
年代:1990
数据来源: Karger
|
10. |
Antiestrogen-Binding Sites in 7,12-Dimethylbenz(a)anthracene-Induced Rat Mammary Tumors: Relation to Growth |
|
Oncology,
Volume 47,
Issue 6,
1990,
Page 495-500
Peter L.H. Hwang,
B.E. How,
Preview
|
PDF (2639KB)
|
|
摘要:
We have detected specific high-affinity binding sites for nonsteroidal antiestrogens in 98% of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors. Since recent studies have suggested that these binding sites may be involved in the regulation of cell growth and proliferation, we attempted to define a possible relationship between the growth of these hormone-dependent tumors and their antiestrogen-binding site content. Rats bearing such tumors were either treated with haloperidol (to increase prolactin secretion and stimulate tumor growth) or oophorectomized (to reduce circulating estrogen concentration and suppress tumor growth). Compared with controls, haloperidol treatment clearly enhanced tumor growth while oophorectomy induced tumor regression, but neither procedure had any effect on the antiestrogen-binding site concentration. Furthermore, tumors which responded to endocrine manipulation had similar antiestrogen-binding site concentrations as tumors which did not respond. We conclude that (1) the alterations in tumor growth induced by these endocrine manipulations are probably not mediated through a change in antiestrogen-binding site concentration, and (2) the tumor concentration of these binding sites is not under estrogen or prolactin control.
ISSN:0030-2414
DOI:10.1159/000226879
出版商:S. Karger AG
年代:1990
数据来源: Karger
|
|